Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started